PMID- 11053014 OWN - NLM STAT- MEDLINE DCOM- 20001109 LR - 20200930 IS - 1040-0605 (Print) IS - 1040-0605 (Linking) VI - 279 IP - 5 DP - 2000 Nov TI - Characterization of rabbit SP-B promoter region responsive to downregulation by tumor necrosis factor-alpha. PG - L806-14 AB - Surfactant protein B (SP-B) is essential for the maintenance of biophysical properties and physiological function of pulmonary surfactant. Tumor necrosis factor-alpha (TNF-alpha), an important mediator of lung inflammation, inhibits surfactant phospholipid and surfactant protein synthesis in the lung. In the present study, we investigated the TNF-alpha inhibition of rabbit SP-B promoter activity in a human lung adenocarcinoma cell line (NCI-H441). Deletion experiments indicated that the TNF-alpha response elements are located within -236 bp of SP-B 5'-flanking DNA. The TNF-alpha response region contained binding sites for nuclear factor-kappa B (NF-kappa B), Sp1/Sp3, thyroid transcription factor (TTF)-1, and hepatocyte nuclear factor (HNF)-3 transcription factors. Inhibitors of NF-kappa B activation such as dexamethasone and N-tosyl-L-phenylalanine chloromethyl ketone and mutation of the NF-kappa B element did not reverse TNF-alpha inhibition of SP-B promoter, indicating that TNF-alpha inhibition of SP-B promoter activity occurs independently of NF-kappa B activation. TNF-alpha treatment decreased the binding activities of TTF-1 and HNF-3 elements without altering the nuclear levels of TTF-1 and HNF-3 alpha proteins. Pretreatment of cells with okadaic acid reversed TNF-alpha inhibition of SP-B promoter activity. Taken together these data indicated that in NCI-H441 cells 1) TNF-alpha inhibition of SP-B promoter activity may be caused by decreased binding activities of TTF-1 and HNF-3 elements, 2) the decreased binding activities of TTF-1 and HNF-3 alpha are not due to decreased nuclear levels of the proteins, and 3) okadaic acid-sensitive phosphatases may be involved in mediating TNF-alpha inhibition of SP-B promoter activity. FAU - Berhane, K AU - Berhane K AD - Department of Molecular Biology, University of Texas Health Science Center at Tyler, Tyler, Texas 75708-3154, USA. FAU - Margana, R K AU - Margana RK FAU - Boggaram, V AU - Boggaram V LA - eng GR - HL-48048/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Physiol Lung Cell Mol Physiol JT - American journal of physiology. Lung cellular and molecular physiology JID - 100901229 RN - 0 (DNA-Binding Proteins) RN - 0 (FOXA1 protein, human) RN - 0 (Hepatocyte Nuclear Factor 3-alpha) RN - 0 (NF-kappa B) RN - 0 (NKX2-1 protein, human) RN - 0 (Nuclear Proteins) RN - 0 (Proteolipids) RN - 0 (Pulmonary Surfactants) RN - 0 (Thyroid Nuclear Factor 1) RN - 0 (Transcription Factors) RN - 0 (Tumor Necrosis Factor-alpha) RN - 6QYI7Y8OBO (mitopodozide) RN - 9000-55-9 (Podophyllin) RN - L36H50F353 (Podophyllotoxin) SB - IM MH - Adenocarcinoma MH - Animals MH - Cell Line MH - Cell Nucleus/metabolism MH - Cytosol/metabolism MH - DNA-Binding Proteins/metabolism MH - Gene Expression Regulation/*drug effects MH - Hepatocyte Nuclear Factor 3-alpha MH - Humans MH - Lung Neoplasms MH - Mutagenesis, Site-Directed MH - NF-kappa B/metabolism MH - Nuclear Proteins/metabolism MH - Podophyllin/*analogs & derivatives/metabolism MH - Podophyllotoxin/analogs & derivatives MH - *Promoter Regions, Genetic MH - Proteolipids/*genetics MH - Pulmonary Surfactants/*genetics MH - Rabbits MH - Thyroid Nuclear Factor 1 MH - Transcription Factors/metabolism MH - Transfection MH - Tumor Cells, Cultured MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 2000/10/29 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/10/29 11:00 PHST- 2000/10/29 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/10/29 11:00 [entrez] AID - 10.1152/ajplung.2000.279.5.L806 [doi] PST - ppublish SO - Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L806-14. doi: 10.1152/ajplung.2000.279.5.L806.